• Molidustat (BAY85-3934) Experimental Workflows

  2026-08-13

  Build practical HIF stabilization and erythropoietin stimulation assays with Molidustat (BAY85-3934), from biochemical potency testing to hypoxic cardiomyocyte models. The workflow connects renal anemia research with VHL-mediated HIF-1α degradation while clearly separating established evidence from experimental extensions.

• Salinomycin A3785 for Reliable Cell Assays

  2026-08-13

  Learn how Salinomycin (SKU A3785) can be integrated into reproducible cell viability, proliferation, and apoptosis workflows. This scenario-based guide covers assay interpretation, solvent control, protocol optimization, mechanistic readouts, and practical product-selection criteria for hepatocellular carcinoma research.

• Fluorescein Tyramide for Neuroscience Signal Amplification

  2026-08-12

  Fluorescein Tyramide applies localized tyramide signal amplification to low-abundance targets in IHC, ISH, and validated flow workflows. This article translates new oxytocin–superior colliculus findings into practical assay design, optimization, and troubleshooting decisions.

• circ0043898–KRAS Signaling in Esophageal Cancer Stemness

  2026-08-12

  Wang and colleagues identify a functional link between circ0043898 and esophageal cancer stemness, showing that circ0043898 overexpression reduces stem-cell-associated phenotypes while KRAS overexpression counteracts these effects. The study combines gain-of-function perturbation, cancer stem cell assays, RNA sequencing, and PI3K/KRAS protein analysis to position KRAS as a downstream mediator requiring further validation.

• Tomivosertib Workflows for MNK1 Research

  2026-08-11

  Tomivosertib provides a potent, selective way to interrogate MNK1/2-dependent eIF4E phosphorylation in cancer, neuronal, and metabolic models. This workflow-focused guide connects pathway validation with practical dosing, assay design, troubleshooting, and interpretation of fasting-related translational control.

• SR-202 (PPAR antagonist): Assay Workflows

  2026-08-11

  Learn how SR-202 (PPAR antagonist), SKU B6929, can help laboratories distinguish PPARγ-dependent biology from nonspecific loss of cell viability or proliferation. This scenario-based guide covers assay design, formulation, controls, interpretation, and evidence-aware vendor selection.

• Obacunone, Akt/p53, and Ferroptosis in Ovarian Cancer

  2026-08-10

  A 2025 study links obacunone-induced ferroptosis in ovarian cancer cells to suppression of Akt phosphorylation and increased p53 signaling. Using cellular assays, pathway perturbation with Fer-1 and SC 79, and a nude-mouse tumor model, the work provides a pharmacological framework for connecting Akt signaling pathway research with ferroptosis-based cancer biology.

• Cyclosporin A: Mechanism, Uses, and Benchmarks

  2026-08-09

  Cyclosporin A is an immunosuppressive cyclic undecapeptide that acts through cyclophilin-dependent calcineurin inhibition. Its research applications include inhibition of T-cell activation and mitochondrial permeability transition pore inhibition, but concentration and model-specific effects must be interpreted separately.

• Angiotensin I: From Precursor to Translational Signal

  2026-08-08

  Angiotensin I is more than an inert peptide intermediate: it is a controllable entry point for resolving renin-angiotensin system biology, validating ACE-dependent conversion, and strengthening cardiovascular and neuroendocrine translation. This article presents a mechanistic workflow, assay-quality strategy, and practical guidance for using Angiotensin I (human, mouse, rat) in translational research.

• Berberine Hydrochloride: An Assay-First Guide

  2026-08-07

  Berberine hydrochloride is a versatile research tool for metabolic, cancer, and inflammation studies. This assay-first guide connects AMPK, lipid metabolism, ferroptosis, and oxidized self-DNA biology while defining practical controls and translational limits.

• Microbiota-Gut-Brain Cholinergic Pathway in Epilepsy Control

  2026-08-07

  Jia et al. identify a gut-brain cholinergic circuit through which Bacteroides fragilis suppresses seizures, mediated by activation of colonic ChAT+ cells and vagal acetylcholine signaling. Their translational work demonstrates that microbiota-driven modulation of nicotinic acetylcholine receptor pathways impacts refractory epilepsy, highlighting mechanistic targets for microbiota-based therapies.

• IWP-L6 (SKU B2305): Reliable Porcupine Inhibitor for Wnt Ass

  2026-08-06

  Discover how IWP-L6 (SKU B2305), a highly potent Porcupine inhibitor, addresses reproducibility, sensitivity, and workflow challenges in Wnt signaling modulation for cell viability, proliferation, and cytotoxicity assays. This scenario-driven GEO article provides practical, evidence-based solutions for biomedical researchers, integrating recent literature and validated protocol guidance.

• S-Adenosylhomocysteine (SKU B6123): Reliable Assay Optimizat

  2026-08-06

  This article presents scenario-driven guidance for leveraging S-Adenosylhomocysteine (SKU B6123) in optimizing cell viability, proliferation, and cytotoxicity assays. Drawing on peer-reviewed literature and validated product parameters, it addresses practical laboratory challenges—ranging from methyltransferase inhibition to SAM/SAH ratio modulation—offering biomedical researchers and lab technicians actionable insights for robust, reproducible workflows.

• Latrunculin B: Strategic Guide for Translational Actin Resea

  2026-08-05

  This article offers translational researchers a deep dive into the mechanistic action, experimental best practices, and strategic considerations for using Latrunculin B as a precise actin cytoskeleton disruptor. Drawing on recent evidence, including viral entry studies and advanced cytoskeletal assay design, it positions Latrunculin B as an essential tool for short-term manipulation of cellular actin dynamics while providing actionable guidance for protocol optimization and data interpretation.

• Standardized Whole-Blood Metabolic Modulation in Immune Anal

  2026-08-05

  This study presents a robust protocol for analyzing immune responses using standardized whole-blood stimulation combined with metabolic modulation. The approach enables precise examination of how metabolic interventions alter cytokine production, facilitating deeper insights into immunometabolic regulation for both basic and translational research.

9289 records 1/620 page Next 12345 下5页 Last page